London, England, United Kingdom Silence Therapeutics appeared to be the Corporate Investor, which was created in 1999. The company was established in Europe in United Kingdom. The main office of represented Corporate Investor is situated in the London.
We can highlight the next thriving fund investment areas, such as Electronics, Biotechnology. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arrowhead Pharmaceuticals.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2000. The high activity for fund was in 2017.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Silence Therapeutics, startups are often financed by RA Capital Management, OrbiMed.
Related Funds
| Fund Name | Location |
| ACG Equity Partners | Charleston, South Carolina, United States |
| Adcock Private Equity | - |
| Capture Investments | - |
| China Trends Holdings | China, Hong Kong, Hong Kong Island |
| DMM.com | Japan, Tokyo |
| Ericsson Ventures | California, Santa Clara, United States |
| Expara IDM Ventures | Central, Central Region, Singapore |
| Fellowes | Illinois, Itasca, United States |
| Glaxo Group | Brentford, Hounslow, United Kingdom |
| Lee Prize for Innovation and Entrepreneurship | Las Vegas, Nevada, United States |
| Micromanagement Ventures | New York, New York, United States |
| NDFOS | Seoul, Seoul-t'ukpyolsi, South Korea |
| Octava | Georgia, Norcross, United States |
| S.A.C. Capital Advisors | Connecticut, Stamford, United States |
| Sino-Ocean Group | Beijing, Beijing, China |
| Yamaguchi Bank | Japan, Shimonoseki, Yamaguchi Prefecture |
| Yaotian Keji | Beijing, China, Pinggu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 